108 related articles for article (PubMed ID: 8640827)
1. Regulation of insulin-like growth factor II P3 promotor by p53: a potential mechanism for tumorigenesis.
Zhang L; Kashanchi F; Zhan Q; Zhan S; Brady JN; Fornace AJ; Seth P; Helman LJ
Cancer Res; 1996 Mar; 56(6):1367-73. PubMed ID: 8640827
[TBL] [Abstract][Full Text] [Related]
2. AP-2 may contribute to IGF-II overexpression in rhabdomyosarcoma.
Zhang L; Zhan S; Navid F; Li Q; Choi YH; Kim M; Seth P; Helman LJ
Oncogene; 1998 Sep; 17(10):1261-70. PubMed ID: 9771969
[TBL] [Abstract][Full Text] [Related]
3. Egr-1 mediates transcriptional activation of IGF-II gene in response to hypoxia.
Bae SK; Bae MH; Ahn MY; Son MJ; Lee YM; Bae MK; Lee OH; Park BC; Kim KW
Cancer Res; 1999 Dec; 59(23):5989-94. PubMed ID: 10606246
[TBL] [Abstract][Full Text] [Related]
4. [Construction of a plasmid vector of fused protein genes driven by human insulin-like growth factor II P3 promoter].
Zhou HK; Yang DH; Tang SH; Huang W; Lu XH
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):106-10. PubMed ID: 16620715
[TBL] [Abstract][Full Text] [Related]
5. Oncogene-induced up-regulation of Caco-2 cell proliferation involves IGF-II gene activation through a protein kinase C-mediated pathway.
Cadoret A; Baron-Delage S; Bertrand F; Kornprost M; Groyer A; Gespach C; Capeau J; Cherqui G
Oncogene; 1998 Aug; 17(7):877-87. PubMed ID: 9780004
[TBL] [Abstract][Full Text] [Related]
6. The human hepatitis B virus transactivator X gene product regulates Sp1 mediated transcription of an insulin-like growth factor II promoter 4.
Lee YI; Lee S; Lee Y; Bong YS; Hyun SW; Yoo YD; Kim SJ; Kim YW; Poo HR
Oncogene; 1998 May; 16(18):2367-80. PubMed ID: 9620554
[TBL] [Abstract][Full Text] [Related]
7. Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression.
Zhang L; Yu D; Hu M; Xiong S; Lang A; Ellis LM; Pollock RE
Cancer Res; 2000 Jul; 60(13):3655-61. PubMed ID: 10910082
[TBL] [Abstract][Full Text] [Related]
8. Dual role for transcription factor AP-2 in the regulation of the major fetal promoter P3 of the gene for human insulin-like growth factor II.
Rietveld LE; Koonen-Reemst AM; Sussenbach JS; Holthuizen PE
Biochem J; 1999 Mar; 338 ( Pt 3)(Pt 3):799-806. PubMed ID: 10051455
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor (VEGF) up-regulates epidermal growth factor receptor (EGF-R) in cervical cancer in vitro: this action is mediated through HPV-E6 in HPV-positive cancers.
Mathur RS; Mathur SP
Gynecol Oncol; 2005 Apr; 97(1):206-13. PubMed ID: 15790460
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional suppression of multidrug resistance-associated protein (MRP) gene expression by wild-type p53.
Wang Q; Beck WT
Cancer Res; 1998 Dec; 58(24):5762-9. PubMed ID: 9865734
[TBL] [Abstract][Full Text] [Related]
11. Osteogenic protein-1 regulates insulin-like growth factor-I (IGF-I), IGF-II, and IGF-binding protein-5 (IGFBP-5) gene expression in fetal rat calvaria cells by different mechanisms.
Yeh LC; Adamo ML; Duan C; Lee JC
J Cell Physiol; 1998 Apr; 175(1):78-88. PubMed ID: 9491783
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus core protein transactivates insulin-like growth factor II gene transcription through acting concurrently on Egr1 and Sp1 sites.
Lee S; Park U; Lee YI
Virology; 2001 May; 283(2):167-77. PubMed ID: 11336542
[TBL] [Abstract][Full Text] [Related]
13. Activation of the insulin-like growth factor II transcription by aflatoxin B1 induced p53 mutant 249 is caused by activation of transcription complexes; implications for a gain-of-function during the formation of hepatocellular carcinoma.
Lee YI; Lee S; Das GC; Park US; Park SM; Lee YI
Oncogene; 2000 Aug; 19(33):3717-26. PubMed ID: 10949925
[TBL] [Abstract][Full Text] [Related]
14. Urokinase type plasminogen activator receptor is involved in insulin-like growth factor-induced migration of rhabdomyosarcoma cells in vitro.
Gallicchio MA; Kaun C; Wojta J; Binder B; Bach LA
J Cell Physiol; 2003 Oct; 197(1):131-8. PubMed ID: 12942549
[TBL] [Abstract][Full Text] [Related]
15. Constitutive or inducible overexpression of the IGF-2 gene in cells of a human colon carcinoma cell line.
Lamonerie T; Lavialle C; de Galle B; Binoux M; Brison O
Exp Cell Res; 1995 Feb; 216(2):342-51. PubMed ID: 7531153
[TBL] [Abstract][Full Text] [Related]
16. p53 regulates human insulin-like growth factor II gene expression through active P4 promoter in rhabdomyosarcoma cells.
Zhang L; Zhan Q; Zhan S; Kashanchi F; Fornace AJ; Seth P; Helman LJ
DNA Cell Biol; 1998 Feb; 17(2):125-31. PubMed ID: 9502429
[TBL] [Abstract][Full Text] [Related]
17. Wild-type p53 down-regulates transcription from oncogenic human papillomavirus promoters through the epithelial specific enhancer.
Desaintes C; Hallez S; Detremmerie O; Burny A
Oncogene; 1995 Jun; 10(11):2155-61. PubMed ID: 7784059
[TBL] [Abstract][Full Text] [Related]
18. Wild-type human p53 activates the human epidermal growth factor receptor promoter.
Deb SP; Muñoz RM; Brown DR; Subler MA; Deb S
Oncogene; 1994 May; 9(5):1341-9. PubMed ID: 8152794
[TBL] [Abstract][Full Text] [Related]
19. Functional and physical interactions between BRCA1 and p53 in transcriptional regulation of the IGF-IR gene.
Abramovitch S; Werner H
Horm Metab Res; 2003; 35(11-12):758-62. PubMed ID: 14710355
[TBL] [Abstract][Full Text] [Related]
20. p53 upregulates death receptor 4 expression through an intronic p53 binding site.
Liu X; Yue P; Khuri FR; Sun SY
Cancer Res; 2004 Aug; 64(15):5078-83. PubMed ID: 15289308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
